MyBlueDots

Red light linked to lowered risk of blood clots

MyBlueDots3 months ago01 mins

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by University of Pittsburgh School of Medicine and UPMC surgeon-scientists and published today in the Journal of Thrombosis and Haemostasis.

Medicare rules may reduce prescription steering

MyBlueDots3 months ago01 mins

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies. However, these pharmacies appear less used in Medicare than in other market segments. These PBMs are part of integrated health care conglomerates that own insurance companies and pharmacies, which may create conflicts of interest.

MyBlueDots

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

MyBlueDots3 months ago01 mins

BERLIN–(BUSINESS WIRE)–Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an investigational gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). All QUANTI studies investigated gadoquatrane at a gadolinium dose of 0.04 mmol Gd/kg body weight which represents a gadolinium dose reduction of 60 percent compared to the macrocyclic GBCAs dosed at 0.

What does it mean to have a ‘mental health crisis’?

MyBlueDots3 months ago01 mins

When we think of a mental health crisis, we often imagine an unpredictable and intense manifestation of a negative mental state.

New study suggests hearing loss may be early indicator of Parkinson’s

MyBlueDots3 months ago01 mins

There may be a link between hearing impairment and an increased risk of developing Parkinson’s according to research led by Lancaster University.

New drug for prostate cancer patients in clinical trials

MyBlueDots3 months ago01 mins

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in the journal Clinical Cancer Research.

Research shows the complexity of childhood trauma

MyBlueDots3 months ago01 mins

“Kids are resilient” is a refrain often repeated as a source of comfort after an incident in childhood. But what if it just isn’t aways true?

New AI-powered app brings infant jaundice screening home for Asian parents

MyBlueDots3 months ago01 mins

For the first two to three weeks of their lives, infants have to undergo screening for neonatal jaundice (NNJ). It typically involves frequent clinic visits, which is not only inconvenient, but vulnerable infants could potentially be exposed to airborne diseases.

Why new precision oncology treatments benefit patients of some ancestries more than others

MyBlueDots3 months ago01 mins

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century have received that approval based on their ability to target genetic changes driving tumor growth.

‘Explant’ technique predicts a tumor’s responsiveness to breast cancer treatment

MyBlueDots3 months ago01 mins

Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer patients will respond to chemotherapy and antibody-directed cancer treatments.

Useful _Links

No needles needed: Wearable glucose monitors could reveal early diabetes warning signs missed by blood tests

Basal cell carcinoma’s low immunogenicity linked to suppression of antigen presentation from its cell of origin

Multiple studies show that children face elevated health risks after COVID infection

Montana has a measles outbreak with its first cases in 35 years. Here’s what you should know

Single-dose psychedelic boosts brain flexibility for weeks, study finds

Medication-induced sterol disruption: A silent threat to brain development and public health

Red light linked to lowered risk of blood clots

Medicare rules may reduce prescription steering

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

What does it mean to have a ‘mental health crisis’?

New study suggests hearing loss may be early indicator of Parkinson’s

New drug for prostate cancer patients in clinical trials

Research shows the complexity of childhood trauma

New AI-powered app brings infant jaundice screening home for Asian parents

Why new precision oncology treatments benefit patients of some ancestries more than others

‘Explant’ technique predicts a tumor’s responsiveness to breast cancer treatment

World News

Useful Links

Health

Business

Entertainment

About Us